Compare Viatris Inc (VTRS) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Viatris Inc vs Vanguard Total International Stock Index Fund ETF — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while Vanguard Total International Stock Index Fund ETF trades at $84.5. The key difference: Viatris Inc pays a 2.83% dividend while Vanguard Total International Stock Index Fund ETF pays none, and Viatris Inc is trading nearer its 52-week high, Vanguard Total International Stock Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| VTRS | VXUS | |
|---|---|---|
Market Cap | $19.79B | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.39 | $87.06 |
52-Week Low | $8.74 | $68.24 |
Enterprise Value | $32.00B | — |
Dividend Yield | 2.83% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
